Abbott takes DexCom to court
This article was originally published in The Gray Sheet
Executive Summary
Patent infringement complaint filed by Abbott in a Delaware district court alleges that DexCom's continuous glucose monitor system is derived from Abbott's patents. Both DexCom (STS) and Abbott (Freestyle Navigator) are vying to reach the U.S. market. DexCom responds that since neither product is commercialized, the firm is "not harming Abbott's current glucose monitoring business in any manner" and that Abbott could not have been able to scientifically investigate the STS. DexCom filed for PMA approval in March (1"The Gray Sheet" Aug. 8, 2005, p. 20)...